← FDA Drug Approvals (Drugs@FDA)
PROHANCE
NDA · New Drug Application · Sponsor: BRACCO · Approved 1992-11-16
Drug application
- FDA Application #
NDA020131- Application type
- New Drug Application
- Brand name
- PROHANCE
- Generic name
- GADOTERIDOL
- Active ingredients
- GADOTERIDOL
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BRACCO
- Manufacturer
- BRACCO DIAGNOSTICS INC
- First approval
- 1992-11-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown